文献速递医学人工智能与信息学临床试验与 GCP

基于AI的胸部X线优先排序在肺癌诊断路径中的随机对照试验

AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial.
PubMed 文献 · Nat Med · 2026-03-24

LungIMPACT随机对照试验评估在初级保健胸部X线检查中,AI优先排序是否缩短至CT和肺癌诊断时间。共分析93,326张X线,AI优先排序组与未排序组的至CT时间中位数均为53天,几何均值比0.97(95%CI 0.93-1.02,P=0.31);至肺癌诊断时间中位数44天对46天,比值0.98(95%CI 0.83-1.16,P=0.84)。AI优先排序对肺癌诊断路径无显著影响,不建议在此场景部署工作列表优先排序。

要点

  • AI优先排序未显著缩短初级保健X线至CT的中位时间(53天对53天)。
  • 至肺癌诊断中位时间44天对46天,差异无统计学意义。
  • AI与放射报告不一致率30.3%,专家复核发现23.9%的可操作发现。

核心结论

  • 在英国初级保健胸部X线场景中,AI优先排序对肺癌诊断路径无显著影响,不应在此场景纳入工作列表优先排序。

研究设计与样本

  • 前瞻性、多中心、随机对照试验,AI优先排序按日随机,两臂均可用AI。
  • 共分析93,326张胸部X线,优先排序开启组45,987张,关闭组47,339张。

主要发现

  • 至CT中位时间均为53天(IQR 17-145天对19-141天),几何均值比0.97(95%CI 0.93-1.02,P=0.31)。
  • 至肺癌诊断中位时间44天(IQR 26-90天)对46天(IQR 24-105天),几何均值比0.98(95%CI 0.83-1.16,P=0.84)。
  • 至急诊转诊时间14天对15天(P=0.13),至治疗时间76天对72.5天(P=0.99),诊断分期差异无统计学意义(P=0.34)。

关键数值与推荐

  • 558人诊断为肺癌,占X线的0.6%。
  • AI与放射报告不一致发生28,261张X线(30.3%),专家复核发现6,750例(23.9%)可操作发现。
  • 14天内完成CT的中位时间两组均为8天(IQR 5-11天)。

临床怎么用

  • 当前证据不支持在初级保健胸部X线流程中部署AI工作列表优先排序以缩短肺癌诊断时间。
  • AI与放射报告不一致率较高,需专家复核可操作发现。

局限性

  • 4,405张X线因数据合规或随机化失败被排除。
  • AI在两臂均可用,可能稀释优先排序的独立效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prioritizing artificial intelligence (AI)-detected imaging findings may reduce the time to diagnosis of lung cancer. This prospective, multicentre, randomized controlled trial tested whether immediate AI prioritization of primary care-requested chest X-rays (CXR) influenced time to computed tomography (CT) and lung cancer diagnosis, the primary outcomes. Secondary outcomes included the number of urgent suspected lung cancer referrals, incidence and stage of lung cancer, times to urgent referral and treatment, concordance between AI and radiology reports, and algorithm accuracy. AI was available in both study arms, with AI prioritization randomized by day. Of 97,731 participant CXRs, 4,405 were excluded due to data compliance issues or failure of randomization, resulting in 93,326 CXRs analyzed (45,987 and 47,339 in the prioritization 'on' or 'off' arms, respectively). A total of 13,347 CTs were identified, with 2,766 performed within 14 days of CXR. Median (interquartile range) times to CT were 53 days (17-145) and 53 days (19-141), with and without AI prioritization, corresponding to a ratio of geometric means of 0.97 (95% confidence interval (CI) = 0.93-1.02; P = 0.31). When restricted to CTs performed within 14 days of CXR, the median time to CT was 8 days (5-11) in both groups. Lung cancer was diagnosed in 558 people (0.6% of CXRs). Median times to diagnosis were 44 days (26-90) and 46 days (24-105) respectively, with a ratio of geometric means of 0.98 (95% CI = 0.83-1.16; P = 0.84). No significant differences were observed in time to lung cancer referral (14 versus 15 days; P = 0.13), time to treatment (76 versus 72.5 days; P = 0.99) or stage at diagnosis (P = 0.34). Discordance between AI and radiology reports occurred in 28,261 CXRs (30.3%) and expert radiology review identified actionable findings in 6,750 cases (23.9%). AI prioritization of CXR requested by UK primary care has no significant impact on the lung cancer pathway. Therefore, CXR AI deployments should not include worklist prioritization in this context. Future research should differentiate between primary pathway changes and the direct impact of AI. ISRCTN registration: 78987039 .

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Woznitza N, Smith L, Rawlinson J, et al. AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial. Nat Med. 2026. PMID: 41876649. doi:10.1038/s41591-026-04253-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。